
Cerbios-Pharma SA
Barbengo, Switzerland cerbios.swiss
From their website, Nov 2026
Work here? Claim this listing
- GMP
About
Cerbios-Pharma SA is a pharmaceutical CDMO in Barbengo-Lugano, Switzerland. It develops and manufactures chemical and biological APIs, including HPAPIs, ADCs, recombinant proteins and antibodies, for partners worldwide from preclinical through commercial supply.
Services
High Potency APIs
Develops and manufactures HPAPIs from early stages through clinical trials to commercial supply, including process development, scale-up, containment, and CMC support.
Antibody Drug Conjugates
Develops and manufactures ADCs and their components, including mAbs, payloads/toxins, and conjugation processes from early stage to commercial supply.
CDMO: development & manufacturing
Proteins & Antibodies
Provides custom development and cGMP production programs for recombinant therapeutic proteins and monoclonal antibodies from cloning to commercial supply.
Protein production
Mammalian cell line and clone generation
Generates mammalian single clones, including vector generation, transfection, single clone isolation, and RCB generation.
Cell line development
Analytical method development and validation
Develops, customizes, and validates analytical methods for biotherapeutics, ADCs, and HPAPIs.
Formulation development
Supports formulation studies and development for proteins, antibodies, and ADC drug substances.
Stability studies
Performs ICH stability studies and stability testing for development and registration support.
CMC and regulatory support
Provides CMC regulatory support, including registrations and submissions for product development and commercial supply.
Live biotherapeutics
Supports fermentation, drying, and stabilization of live biotherapeutic products.
CDMO: development & manufacturing
Drug substance manufacturing
Manufactures drug substances for chemical and biological programs, including recombinant proteins, antibodies, HPAPIs, and ADCs.
CDMO: development & manufacturing
Capabilities
- Assays and studies
- ADCs · Antibodies · Process development · Analytical development · Stability studies · HPLC · ELISA · HPLC-SEC · RP-HPLC · HIC · PLRP · CE
9 more
HILIC · nanoDSF · DSC · CIEF · CE-SDS · LC-MS · Potency testing · qPCR · DSF - Scale and capacity
- HPAPI batch sizes from 5 grams to 35 kg/batch · HPAPI production units: 5 units fully isolated and contained · HPAPI cGMP unit 10–100 gm/batch · HPAPI cGMP modular units 200 gm–2 kgs/batch · HPAPI cGMP unit 5–35 kgs/batch · HPAPI non-cGMP unit up to 50 gm · Drug product non-cGMP unit up to 100 g · Bioreactors up to 40 L · Cell culture bioreactors up to 100 L upgradable to 500 L · Single-use reactors 5 L–200 L
- Therapeutic areas
- CNS · Animal health
Instruments and platforms
- HPLC
- UPLC-DAD/FLD
- LC-MS
- nanoDSF
- DSC
- CE-SDS
- cIEF
- qPCR
- High resolution whole well imaging system
- TFF
- Bio-Chromatography
Modalities and species
- Modalities
- Small molecule · Antibody · ADC · Recombinant protein
- Species and models
- CHO-K1 · CHO-DG44 · PER-C6 · NS0 · mAb · Recombinant proteins
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
As listed: cGMP
Company
- Type
- CRDMO
- Founded
- 1993
Locations
- Based in
- Barbengo, Switzerland
- Sites
- Barbengo/Lugano, Switzerland
- Serves
- worldwide, over 60 countries
Public records
- EU GMP certificate (EudraGMDP)
- GMPEHV-CH-1008421 source
Similar labs
Work here? Claim this listing